loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Original DAS: Developed in 1983
DAS-28: Developed in 1995
A another version with a different scoring exists: DAS-28 CRP
DAS and DAS-28 differ in joint counts
WEBINAR: An Author Webinar on the Disease Activity Score - Recorded session available here!
As the DAS includes both clinical and patient assessments, only patient assessment is described below
van Riel PL
Arthritis, Rheumatoid
Prevoo, M. L., van 't Hof, M. A. , Kuper, H. H. , van Leeuwen, M. A. , van de Putte, L. B. , van Riel, P. L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38;1: 44-8. (Full text article)
Prevoo, M. L. , van Riel, P. L. , van 't Hof, M. A. , van Rijswijk, M. H. , van Leeuwen, M. A. , Kuper, H. H. , van de Putte, L. B. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol. 1993;32;7: 589-94. (PubMed abstract)
Prevoo, M. L. , van Gestel, A. M. , van, T. Hof M. A. , van Rijswijk, M. H. , van de Putte, L. B. , van Riel, P. L. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996;35;11: 1101-5. (PubMed abstract)
van der Heijde DM, van't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis. 1992 Feb;51(2):177-81 (Full text article)
van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990 Nov;49(11):916-20 (Full text article)
van Riel PL
Prof. dr. Piet L.C.M. van Riel
Principle Investigator
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.
Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.
Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Please refer to the "Contact and conditions of use" tab
Handheld
Access to advanced descriptions of Clinical Outcome Assessments (COAs)